AusBiotech and Johnson & Johnson

2018 Industry Excellence Awards

Each year, the Johnson & Johnson Innovation Industry Excellence Awards are presented at the AusBiotech national conference to recognise the highest achievers in the Australian life sciences. From researchers who successfully translate their discoveries to clinical practice, to companies who pioneer the developments of new treatments and reliable diagnostics, these prestigious Awards recognise the leading lights of Australia’s world-class biotechnology, medical technology and healthcare sectors.  

Nominations are open until Friday 28 September 2018 in the following categories:

Industry Leadership Award

This award seeks candidates who have already made a significant difference to the industry and have an outstanding commitment to life sciences/biotechnology that often goes beyond the 'job description'. Candidates will be known for their passion, enthusiasm and commitment to the industry in Australia.

Australian Company of the Year

The Australian Company of the Year will be awarded to a company that has demonstrated significant achievement/s, and may include any company working in biotechnology or life sciences, including but not limited to the medical diagnostics or devices, pharmaceutical and agricultural biotechnology sectors. Criteria for companies may include deals done, product pipeline, IP, company strategy and/or revenue.

Australian Emerging Company of the Year

The Emerging Company of the Year award will be based on the same criteria as the previous category, but be specific to companies under five years of age.


Nomination Process

Nominations of up to 400 words are invited, outlining why the nominated individual/company should be awarded a Johnson & Johnson Innovation 2018 Industry Excellence Award, according to the applicable category and criteria. All applicants must be headquartered in Australia. Organisations with existing commercial interests owned by Johnson & Johnson or subsidiaries of Johnson & Johnson are not eligible. Staff/Board members and their associated organisations of Johnson & Johnson and AusBiotech are not eligible.

Please forward your nomination to the Events Team at / 03 9828 1400 or contact us if you have any queries.


Congratulations to the 2017 Winners

The AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards were announced at the AusBiotech 2017 national conference in Adelaide.  The Awards recognise innovative companies and individuals in Australia’s world-class biotechnology, medical technology and healthcare sectors.

Ms Kathy Connell, senior director New Ventures, ANZ, Johnson & Johnson Innovation, said: “These award recipients are aiming to improve the health of people across the globe, which is an incredibly important mission and we are delighted to sponsor these awards that help recognise this important work.” 

AusBiotech CEO, Glenn Cross, said each award recipient had made a significant contribution to the sector, and to the ongoing growth of Australia’s biotechnology and medical technology, as well as the health of Australians.

“These awards recognise the excellence in our industry,” said Mr Cross. “They also encourage us with what can be achieved when innovation is accompanied by the business acumen needed to bring novel medicines, medical devices and other new technologies to patients.”

Industry Leadership Award: Mrs Lusia Guthrie

With over 35 years in the pharmaceutical, medtech and bioscience industries, Mrs Lusia Guthrie is the chair of Clever Culture Systems AG, LBT Innovations’ joint venture based in Zurich. She holds Board positions with the BioMelbourne Network and ANDHealth and was recently appointed chair of the Medicines Manufacturing Innovation Centre at Monash Institute of Pharmaceutical Sciences. Mrs Guthrie also holds industry advisory committee positions with the Australian Centre for Visual Technology at the University of Adelaide and the Australian Regenerative Medicine Institute at Monash University. 

Company of the Year: Planet Innovation

Over the last 12 months, Planet Innovation (PI) has raised the profile of the Australian biotechnology industry through sustained company success, breakthrough innovations and proactive thought-leadership. During this time, PI doubled its company revenue, created over 100 new jobs for the Australian biotechnology sector, and more than tripled its manufacturing export revenues of biomed and life-science products.

Emerging Company of the Year: CancerAid

CancerAid has developed a smartphone application for cancer patients, caregivers and clinicians. This digital health tool is designed to address key issues faced in oncology to provide value-added services. Launched last year, the App has quickly become the number one cancer app in Australia, the US and the UK. 

 Mrs Lusia Guthrie

 Planet Innovation


Find out more about past recipients.  

AusBiotech would like to thank Johnson & Johnson Innovation for their continued support of these awards.